Investor Relations
MAP Pharmaceuticals is an innovative drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place better care into patients' hands by enhancing how proven drugs perform, through targeted dosing regimens and novel delivery systems. MAP Pharmaceuticals' goal is to develop treatments that provide patients with greater control, improved efficacy and fewer side effects.
Recent Releases
Jan 17, 2012
MAP Pharmaceuticals Appoints W. James O'Shea to Board of Directors
Jan 4, 2012
MAP Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Nov 8, 2011
MAP Pharmaceuticals Reports Third Quarter of 2011 Financial Results
